135 related articles for article (PubMed ID: 120451)
1. [Studies on complement system in multiple myeloma and Waldenström's macroglobulinemia--specific patterns and their clinical significance (author's transl)].
Kuribayashi K
Rinsho Ketsueki; 1979 Oct; 20(10):1306-13. PubMed ID: 120451
[No Abstract] [Full Text] [Related]
2. [Studies of peripheral blood lymphocytes subpopulation in multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy (author's transl)].
Matsuda S; Kimura H; Tanaka T; Akizuki T; Yoshida H; Uchida T; Kariyone S
Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):485-92. PubMed ID: 99942
[No Abstract] [Full Text] [Related]
3. [Immunoglobulin levels in the serum of patients with myeloma and Waldenström's macroglobulinemia].
Linz R; Lecocq E
C R Seances Soc Biol Fil; 1971; 165(5):1191-4. PubMed ID: 4261510
[No Abstract] [Full Text] [Related]
4. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease].
Meier EC; Grob PJ
Dtsch Med Wochenschr; 1972 Jun; 97(25):967-71. PubMed ID: 4624059
[No Abstract] [Full Text] [Related]
5. [Immunoglobulin E in patients with chronic lymphocytic leukaemia, multiple myeloma and morbus Waldenström (author's transl)].
Schwarz S; Gabl F; Pastner D; Huber H; Braunsteiner H
Z Immunitatsforsch Exp Klin Immunol; 1974 Dec; 148(3):196-207. PubMed ID: 4283033
[No Abstract] [Full Text] [Related]
6. [Identification and importance of the 7S subunity in Waldenström's macroglobulinemia (author's transl)].
Somoza-Martínez R; Gallango ML
Rev Invest Clin; 1974; 26(4):355-62. PubMed ID: 4218345
[No Abstract] [Full Text] [Related]
7. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
Tanaka E
Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
[No Abstract] [Full Text] [Related]
8. Immunofluorescence studies in Waldenström's macroglobulinemia.
Preud'homme JL; Hurez D; Seligmann M
Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1127-31. PubMed ID: 4996339
[No Abstract] [Full Text] [Related]
9. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
Kraj M; Maj S; Rostkowska J
Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal gammapathies. (Critical review of 219 cases collected over 3 years)].
Youinou P; Le Goff P; Saleun JP; Jouquan J; Tymen G; Le Menn G
Pathol Biol (Paris); 1977 Oct; 25(8):517-21. PubMed ID: 413086
[TBL] [Abstract][Full Text] [Related]
11. [Reaction between the first component C1 of the complement system and immunoglobulins in relation to their class, subclass and physical condition].
Augener W; Grey HM; Cooper NR; Müller-Eberhard HJ
Verh Dtsch Ges Inn Med; 1971; 77():1163-5. PubMed ID: 5005546
[No Abstract] [Full Text] [Related]
12. [Intravenous immunoglobulin substitution in patients with multiple myeloma, Waldenstrom's syndrome and chronic lymphatic leukemia with secondary antibody deficiency syndrome].
Schedel I
Beitr Infusionther Klin Ernahr; 1983; 11():52-8. PubMed ID: 6418137
[No Abstract] [Full Text] [Related]
13. [Clinical use of intravenous immunoglobulins in bacterial infections in multiple myeloma and Waldenström's macroglobulinemia].
Paladini G; Mazzanti G; Piccinini C; Fabiani MG; Parma A; Zulli L; Tosato F
Recenti Prog Med; 1988 Mar; 79(3):105-10. PubMed ID: 3134678
[No Abstract] [Full Text] [Related]
14. [Immunochemical characterization of the L-chains and H-chains of monoclonal immunoglobulins in multiple myeloma, Waldenstrom's disease and heavy chain disease].
Tischendorf FW
Med Welt; 1968 Nov; 46():2531-6. PubMed ID: 4183339
[No Abstract] [Full Text] [Related]
15. Tumoral joint involvement in multiple myeloma and Waldenström's macroglobulinemia--report of 4 cases.
Roux S; Fermand JP; Brechignac S; Mariette X; Kahn MF; Brouet JC
J Rheumatol; 1996 Dec; 23(12):2175-8. PubMed ID: 8970062
[TBL] [Abstract][Full Text] [Related]
16. [Multiple myeloma or Waldenstrom's macroglobulinemia?].
Sawicka B; Burghart-Czaplińska M
Pol Tyg Lek; 1977 Apr; 32(16):609-10. PubMed ID: 404632
[No Abstract] [Full Text] [Related]
17. Multiple myeloma and Waldenström's macroglobulinemia terminating in acute leukemia. Review with emphasis on karyotypic and ultrastructural abnormalities.
Rosner F; Grünwald HW
N Y State J Med; 1980 Mar; 80(4):558-70. PubMed ID: 6767209
[No Abstract] [Full Text] [Related]
18. [Neurologic manifestations of monoclonal gammapathies].
Uldry PA; Steck AJ; Regli F
Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
[TBL] [Abstract][Full Text] [Related]
19. [The blood coagulation system in patients with Waldenstrom's macroglobulinemia and multiple myeloma].
Kokeva RA; Zhuravlev VS
Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):10-5. PubMed ID: 4981865
[No Abstract] [Full Text] [Related]
20. Reduced complement activity in sera of patients with Waldenström's macroglobulinemia.
Glovsky M; Fudenberg HH
J Immunol; 1970 May; 104(5):1072-8. PubMed ID: 4986367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
